Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

scientific article published on 01 June 1990

Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1001/ARCHOPHT.1990.01070080058036
P698PubMed publication ID1693496

P433issue6
P921main subjectlight coagulationQ73523884
kryptonQ888
laserQ38867
P304page(s)816-824
P577publication date1990-06-01
P1433published inJAMA OphthalmologyQ4787301
P1476titleKrypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group
P478volume108

Reverse relations

cites work (P2860)
Q30912261A pilot study of ICG-guided laser photocoagulation for occult choroidal neovascularization presenting as a focal spot in age-related macular degeneration
Q71692991Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation
Q36696019Age-related macular degeneration and choroidal neovascularization.
Q33263472Age-related macular degeneration--emerging pathogenetic and therapeutic concepts
Q32004815Age-related macular degeneration: a review of experimental treatments
Q38178644Age-related macular degeneration: beyond anti-angiogenesis
Q30666801Age-related macular degeneration: cost-of-illness issues
Q31048292Age-related macular degeneration: epidemiology and optimal treatment
Q30749075Angiographic pattern of recurrent choroidal neovascularization in age-related macular degeneration
Q44443130Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration
Q36830200Assessment of visual function in choroidal neovascularization with scanning laser microperimetry and simultaneous indocyanine green angiography
Q73211609Choroidal neovascularization in second eyes of patients with unilateral exudative age-related macular degeneration
Q67464768Clinical Evaluation of Indocyanine Green Video-Angiography in the Diagnosis of Choroidal Neovascular Membrane Associated with Age-Related Macular Degeneration
Q33227800Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results
Q30699719Clinical significance of postlaser indocyanine green angiographic hot spots in age-related macular degeneration
Q33460962Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation
Q48304782Comparison of serum thiol-disulphide homeostasis and total antioxidant-oxidant levels between exudative age-related macular degeneration patients and healthy subjects
Q35509833Complement, age-related macular degeneration and a vision of the future
Q36838817Diode laser photocoagulation of choroidal neovascular membranes
Q32118775Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration
Q30773162External beam radiotherapy for subretinal neovascularization in age-related macular degeneration: is this treatment efficient?
Q30716823Fluorescein angiographic abnormalities after prophylactic macular photocoagulation for high-risk age-related maculopathy.
Q36070331Hearing and visual impairments
Q36673982Indocyanine green angiography and occult choroidal neovascularization
Q36862075Indocyanine green hyperfluorescence associated with serous retinal pigment epithelial detachment in age-related macular degeneration
Q24811544Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635].
Q36977415Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration
Q36699430Laser energy and dye fluorescence transmission through blood in vitro
Q30887038Laser eye injuries
Q24247642Laser photocoagulation for choroidal neovascularisation in myopic macular degeneration
Q24244141Laser photocoagulation for neovascular age-related macular degeneration
Q24247594Laser photocoagulation for neovascular age-related macular degeneration
Q36697469Laser treatment of choroidal neovascularization in patients with angioid streaks.
Q36675477Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration.
Q26767095Management of Neovascular Age-related Macular Degeneration: A Review on Landmark Randomized Controlled Trials
Q30806788Methylprednisolone therapy for retinal laser injury
Q50514148Near-infrared (NIR) laparoscopy for intraoperative lymphatic road-mapping and sentinel node identification during definitive surgical resection of early-stage colorectal neoplasia.
Q35704053Neuroprotection in ophthalmology: a review
Q35016867Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis)
Q36814558Optical coherence tomography of age-related macular degeneration and choroidal neovascularization
Q36837327Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results
Q32138422Phenotypic heterogeneity in families with age-related macular degeneration
Q45239423Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP study. One- and two-year results including juxtafoveal and extrafoveal CNV.
Q44767170Photodynamic therapy. Foreword
Q34416380Photosensitizer delivery for photodynamic therapy of choroidal neovascularization
Q47361893Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration.
Q26799548Polypoidal Choroidal Vasculopathy in Asians
Q74071278Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration
Q36800399Radiation therapy for subretinal neovascularization
Q31933114Radiotherapy for age-related macular degeneration
Q34534297Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.
Q30653873Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration.
Q33291179Retinal function and PKC alpha expression after focal laser photocoagulation
Q72650582Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration?
Q36831395Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes
Q71701307Selective use of indocyanine green angiography for occult choroidal neovascularization
Q74148616Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration
Q57099862Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: i. ophthalmic outcomes submacular surgery trials pilot study report nu
Q57099876Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: ii. quality of life outcomes submacular surgery trials pilot study rep
Q36696619Subretinal endophotocoagulation in the treatment of choroidal neovascularization.
Q34081868Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11.
Q30990180Surgical management of subfoveal choroidal neovascularization
Q71686759Surgical removal of idiopathic, myopic and age-related subfoveal neovascularization
Q34655539The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1.
Q34651797The Age-Related Eye Disease Study: a clinical trial of zinc and antioxidants--Age-Related Eye Disease Study Report No. 2
Q36768587The Diagnostic Accuracy of Optical Coherence Tomography Angiography for Neovascular Age-Related Macular Degeneration: A Comparison with Fundus Fluorescein Angiography
Q47183944The estimation of approximate sample size requirements necessary for clinical and epidemiological studies in vision sciences
Q34161956The past, present, and future of exudative age-related macular degeneration treatment
Q30883222The role of submacular surgery in the treatment of choroidal neovascular membranes
Q46527056The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study
Q74821681The use of corticosteroids for choroidal neovascularisation in young patients
Q73939433Treatment of age-related macular degeneration
Q33232109Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration
Q71640378Visual results after surgical removal of subfoveal choroidal neovascular membranes

Search more.